This chapter offers a comprehensive comparison of advanced hemodynamic monitoring methods by evaluating the well-established pulmonary artery catheter (PAC) alongside emerging semi-invasive and minimally invasive techniques. It outlines the evolution and clinical utility of PACs, emphasizing their role in managing critically ill patients with conditions such as acute myocardial infarction (MI), acute respiratory distress syndrome (ARDS), cardiogenic shock (CS), and those undergoing transplant evaluation. Although PACs provide accurate measurements of cardiac output (CO), pulmonary artery (PA) pressures, and mixed venous oxygen saturation, their diagnostic precision is counterbalanced by risks such as arrhythmias, infections, thromboembolic events, and potential data misinterpretation. Major clinical trials—including PAC-MAN, ESCAPE, VASST, and FACTT—demonstrate that despite their utility, the routine use of PACs does not consistently translate into enhanced survival outcomes across diverse patient populations. In contrast, less invasive approaches using pulse wave analysis, Doppler-based techniques, and thermodilution—employed in systems like PiCCO, VolumeView, LiDCO, FloTrac, ProAQT/PulsioFlex, Argos, and MostCare—offer benefits such as reduced procedural risks, real-time data acquisition, and easier usability, though they may encounter issues with calibration, signal dependency, and accuracy in hemodynamically unstable patients. Ultimately, while PACs remain crucial in select high-acuity scenarios, these innovative alternatives support a more individualized and safer approach to cardiovascular monitoring across a wide range of clinical settings.